Clover Health announces 2026 Medicare Advantage plans, emphasizing affordable PPO options and enhanced benefits for seniors.
Quiver AI Summary
Clover Health Investments, Corp. has announced its 2026 Medicare Advantage offerings, highlighting its commitment to affordable PPO plans amid a trend toward narrower HMO networks in the industry. As the Annual Enrollment Period begins, Clover is maintaining low or $0 monthly premiums and ensuring that all members will experience stable or improved benefits. CEO Jamie Reynoso emphasized the importance of provider choice for seniors navigating rising costs and fewer options. Clover's plans are designed around principles of affordability, flexibility, predictability, and value, offering comprehensive services including a rewards program and direct member support. The company's AI-driven Clover Assistant platform aids healthcare providers in better managing chronic diseases, contributing to Clover’s significant growth in membership. Available to 5.2 million Medicare-eligible beneficiaries across five states, the plans are positioned to enhance health outcomes and member satisfaction.
Potential Positives
- Clover Health is reinforcing its leadership in the Medicare Advantage market by continuing to offer affordable, high-choice PPO plans amidst a trend of narrowing networks in the industry.
- All Clover Health members are assured stable or improved benefits for 2026, supporting the company's commitment to continuity and predictability for seniors.
- The introduction of enhanced benefits, including access to wellness programs and direct support services, demonstrates Clover's focus on whole-person health for its members.
- Clover Health's 32% year-over-year growth in Medicare Advantage members highlights the effectiveness of its approach and the increasing demand for its services, positioning the company favorably in the market.
Potential Negatives
- While Clover Health claims to provide stability and predictability for its members, the overall Medicare Advantage market is facing challenges, including rising costs and reduced plan choices, which may lead to skepticism about the company's promises of benefits.
- The need to emphasize the enhancement of benefits could indicate previous inadequacies or competitive shortcomings compared to industry trends, suggesting that the company's offerings may not have been as robust previously.
- The reliance on the AI-powered Clover Assistant platform for improving health outcomes raises concerns about data privacy and security for patients, as trust in new technology can be a significant issue in the healthcare industry.
FAQ
What are Clover Health's 2026 Medicare Advantage offerings?
Clover Health offers affordable PPO plans including $0 to low monthly premiums and enhanced benefits for seniors in 2026.
When does the 2026 Annual Enrollment Period begin?
The 2026 Annual Enrollment Period runs from October 15 to December 7, 2025.
How does Clover ensure stable benefits for its members?
Clover Health guarantees that 100% of its members will have stable or improved benefits for 2026, prioritizing continuity and choice.
What key principles guide Clover Health Medicare Advantage plans?
Clover’s plans focus on affordability, flexibility, predictability, and value, with meaningful extra benefits at no additional cost.
How does Clover Assistant improve healthcare outcomes?
Clover Assistant uses AI to aggregate patient data, enabling earlier interventions and better management of chronic diseases.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CLOV Insider Trading Activity
$CLOV insiders have traded $CLOV stock on the open market 12 times in the past 6 months. Of those trades, 4 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:
- VIVEK GARIPALLI has made 2 purchases buying 446,980 shares for an estimated $998,996 and 0 sales.
- CONRAD WAI (CEO, Counterpart Health) has made 0 purchases and 2 sales selling 209,797 shares for an estimated $692,968.
- JAMIE L. REYNOSO (CEO, Medicare Advantage) has made 0 purchases and 6 sales selling 56,000 shares for an estimated $155,511.
- ANNA U LOENGARD has made 2 purchases buying 26,500 shares for an estimated $68,755 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLOV Hedge Fund Activity
We have seen 118 institutional investors add shares of $CLOV stock to their portfolio, and 89 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 20,029,317 shares (+193.2%) to their portfolio in Q2 2025, for an estimated $55,881,794
- GEODE CAPITAL MANAGEMENT, LLC added 4,812,368 shares (+95.7%) to their portfolio in Q2 2025, for an estimated $13,426,506
- MILLENNIUM MANAGEMENT LLC removed 4,745,791 shares (-81.8%) from their portfolio in Q2 2025, for an estimated $13,240,756
- STATE STREET CORP added 4,580,664 shares (+156.5%) to their portfolio in Q2 2025, for an estimated $12,780,052
- VANGUARD GROUP INC added 3,665,917 shares (+17.8%) to their portfolio in Q2 2025, for an estimated $10,227,908
- BANK OF AMERICA CORP /DE/ added 2,748,783 shares (+217.5%) to their portfolio in Q2 2025, for an estimated $7,669,104
- NORTHERN TRUST CORP added 2,341,788 shares (+226.4%) to their portfolio in Q2 2025, for an estimated $6,533,588
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CLOV Analyst Ratings
Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 08/07/2025
To track analyst ratings and price targets for $CLOV, check out Quiver Quantitative's $CLOV forecast page.
$CLOV Price Targets
Multiple analysts have issued price targets for $CLOV recently. We have seen 2 analysts offer price targets for $CLOV in the last 6 months, with a median target of $3.55.
Here are some recent targets:
- Richard Close from Canaccord Genuity set a target price of $4.1 on 08/07/2025
- Jonathan Yong from UBS set a target price of $3.0 on 08/06/2025
Full Release
JERSEY CITY, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company dedicated to bringing access to great healthcare to everyone on Medicare, today announced its 2026 Medicare Advantage offerings, reinforcing Clover’s leadership in affordable, high-choice PPO plans that deliver real results for seniors and physicians alike as the Annual Enrollment Period opens.
While the industry shifts toward narrower HMO networks, Clover continues to offer a robust portfolio of PPO plans featuring $0 to low monthly plan premium MAPD PPOs and $0 monthly plan premium MA only plans with a Part B Giveback. The Company has ensured that 100% of its members will have stable or improved benefits for 2026, reinforcing its commitment to continuity and predictability for seniors who value provider choice and accessibility.
"Many seniors are now navigating a landscape of fewer plan choices and rising costs. Our 2026 offerings are a direct reflection of our unwavering commitment to put their needs first," said Jamie Reynoso, CEO of Medicare Advantage at Clover Health. "By preserving our PPO plans and enhancing our benefits, we are ensuring our members have the stability, choice predictability, and value they deserve, especially when others are pulling back."
Clover Health Medicare Advantage Plans maintain four key principles:
- Affordability: Plans offer a wide range of $0 to low monthly plan premium MAPD plans, including options that pair well with the federal Extra Help program.
- Flexibility: Members enjoy open access to a large network of hospitals and providers with no referrals required to see specialists.
- Predictability: Clover Health plans are designed with a focus on simple copays rather than complex coinsurance, allowing members to better anticipate their healthcare expenses.
- Value: Every plan is built to support whole-person health, providing meaningful extra benefits at no additional cost including fitness, dental, vision, and hearing. All members are also eligible for the LiveHealthy Rewards program. In addition, Clover offers direct support to members via its Clover Care Services arm, which includes welcome-home visits for members coming out of acute care facilities, an active cancer support program, and direct-to-home hospice and palliative care support services for members with acute illness.
Clover’s ability to maintain and enhance benefits is underpinned by the AI-powered Clover Assistant platform that aggregates patient data across the healthcare ecosystem to support clinical decision-making and improve health outcomes through early identification and management of chronic disease. For example, data shows that doctors empowered with Clover Assistant start their diabetes patients on oral medications three years earlier on average. Earlier intervention has been associated with reduced reliance on insulin and lower incidence of hypoglycemia. Similarly, doctors empowered with Clover Assistant diagnose and manage chronic kidney disease over 1.5 years earlier. This earlier intervention has been associated with decelerating decline of kidney function for CKD patients. This model has contributed to Clover’s sustainable 32% year-over-year growth in MA members and, most importantly, can improve both outcomes and quality of life.
The 2026 Annual Enrollment Period runs from October 15 to December 7, 2025. Clover Health plans will be accessible by 5.2 million Medicare-eligible beneficiaries in 2026, within 203 counties across 5 states. Plans available based on location are available to view here .
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on
Medication Adherence
,
Congestive Heart Failure
, and
Chronic Obstructive Pulmonary Disease
as well as the earlier identification and management of
Diabetes
and
Chronic Kidney Disease
.
Visit: www.cloverhealth.com
Investor Relations:
Ryan Schmidt
Press Inquiries:
Clover Health is a Preferred Provider Organization (PPO) and a Health Maintenance Organization (HMO) with a Medicare contract. Enrollment in Clover Health depends on contract renewal.
Y0129_25EX130_C
